Risperdal Gynecomastia Suit Dismissed; Warning Adequate, No Causation Testimony
BROOKLYN, N.Y. — A New York federal judge on June 29 granted summary judgment in a Risperdal gynecomastia case, finding that the drug’s various labels warned of the risk and that...To view the full article, register now.
Already a subscriber? Click here to view full article